Depression, anxiety pill prescriptions rise post-pandemic

In 2022, overall prescriptions grew 1% from 2019 while mental health-related prescriptions increased 12%, USA Today reported Feb. 29. 

Advertisement

An analysis of Medicaid data of the 60 most popular psychiatric drugs found a hike in medications for depression, anxiety and attention-deficit/hyperactivity disorder. Prescriptions for sertraline, the generic for Zoloft and most common antidepressant, rose 17% in those three years. 

Before the COVID-19 pandemic, the utilization of mental health therapies were on the rise, but the pandemic accelerated the trend. According to a recent Census Bureau survey, the percentage of people experiencing anxiety or depression is double prepandemic levels. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.